Applying biotechnology and bioengineering to pediatric lung disease: emerging paradigms and platforms

by Kelley L Colvin, Michael E Yeager
Published 2015-06-01

What people with Down Syndrome can teach us about cardiopulmonary disease

by Kelley L. Colvin, Michael E. Yeager
Published 2017-02-01

Biomarkers for pediatric pulmonary arterial hypertension – a call to collaborate

by Kelley L Colvin, Kelley L Colvin, Kelley L Colvin, Melanie J Dufva, Ryan P Delaney, D Dunbar Ivy, Kurt R Stenmark, Kurt R Stenmark, Michael E Yeager, Michael E Yeager, Michael E Yeager
Published 2014-02-01

Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome

by Katherine A. Waugh, Paula Araya, Ahwan Pandey, Kimberly R. Jordan, Keith P. Smith, Ross E. Granrath, Santosh Khanal, Eric T. Butcher, Belinda Enriquez Estrada, Angela L. Rachubinski, Jennifer A. McWilliams, Ross Minter, Tiana Dimasi, Kelley L. Colvin, Dmitry Baturin, Andrew T. Pham, Matthew D. Galbraith, Kyle W. Bartsch, Michael E. Yeager, Christopher C. Porter, Kelly D. Sullivan, Elena W. Hsieh, Joaquin M. Espinosa
Published 2019-11-01